Literature DB >> 14657718

Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas.

Richard A Scolyer1, Helen M Shaw, John F Thompson, Ling-Xi L Li, Marjorie H Colman, Sing Kai Lo, Stanley W McCarthy, A Allan Palmer, Katherine D Nicoll, Bish Dutta, Eric Slobedman, Geoff F Watson, Jonathan R Stretch.   

Abstract

BACKGROUND: The prognosis for patients with localized primary cutaneous melanoma is known to depend principally on tumor thickness, and to a lesser extent on ulcerative state and Clark level. We have recently found in an analysis of 3661 patients that tumor mitotic rate (TMR) is also an important prognostic parameter, ranking second only to tumor thickness. However, few studies have assessed the accuracy and reproducibility with which these features of a melanoma are recorded by histopathologists. AIM: To assess interobserver reproducibility of major pathologic prognostic parameters in cutaneous melanoma.
METHODS: Single hematoxylin and eosin-stained slides of 69 dermally invasive primary cutaneous melanomas were circulated among six pathologists with differing experience in the assessment of melanocytic tumors. The observers independently determined the tumor thickness, Clark level of invasion, ulcerative state, and TMR for each lesion. Intraclass correlation coefficients and kappa scores for multiple ratings per subject were calculated.
RESULTS: The intraclass correlation coefficients were 0.96 for tumor thickness and 0.76 for TMR. The kappa scores were 0.83 for ulcerative state and 0.60 for Clark level. These results indicated excellent agreement among the pathologists for measurements of tumor thickness, ulcerative state, and TMR and fair to good agreement for Clark level.
CONCLUSIONS: Appropriately trained and experienced histopathologists can assess prognostically important features of melanomas accurately and reproducibly. Given our recent finding of the significance of TMR in determining prognosis, it is important that this feature be assessed by a standardized method and documented for all primary cutaneous melanomas.

Entities:  

Mesh:

Year:  2003        PMID: 14657718     DOI: 10.1097/00000478-200312000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

1.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.

Authors:  John F Thompson; Seng-Jaw Soong; Charles M Balch; Jeffrey E Gershenwald; Shouluan Ding; Daniel G Coit; Keith T Flaherty; Phyllis A Gimotty; Timothy Johnson; Marcella M Johnson; Stanley P Leong; Merrick I Ross; David R Byrd; Natale Cascinelli; Alistair J Cochran; Alexander M Eggermont; Kelly M McMasters; Martin C Mihm; Donald L Morton; Vernon K Sondak
Journal:  J Clin Oncol       Date:  2011-04-25       Impact factor: 44.544

2.  Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival.

Authors:  Rajmohan Murali; Richard A Scolyer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

3.  The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Authors:  Michael W Piepkorn; Raymond L Barnhill; David E Elder; Stevan R Knezevich; Patricia A Carney; Lisa M Reisch; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2013-10-28       Impact factor: 11.527

4.  Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.

Authors:  Edmund K Bartlett; Phyllis A Gimotty; Andrew J Sinnamon; Heather Wachtel; Robert E Roses; Lynn Schuchter; Xiaowei Xu; David E Elder; Michael Ming; Rosalie Elenitsas; DuPont Guerry; Rachel R Kelz; Brian J Czerniecki; Douglas L Fraker; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2013-10-12       Impact factor: 5.344

Review 5.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.

Authors:  Richard A Scolyer; Georgina V Long; John F Thompson
Journal:  Mol Oncol       Date:  2011-03-21       Impact factor: 6.603

6.  Interobserver reproducibility of histological features in cutaneous malignant melanoma.

Authors:  C Urso; F Rongioletti; D Innocenzi; C Saieva; D Batolo; S Chimenti; R Filotico; R Gianotti; M Lentini; C Tomasini; A Rebora; M Pippione
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

7.  Pitfalls and important issues in the pathologic diagnosis of melanocytic tumors.

Authors:  Stanley W McCarthy; Richard A Scolyer
Journal:  Ochsner J       Date:  2010

8.  Variability in mitotic figures in serial sections of thin melanomas.

Authors:  Stevan R Knezevich; Raymond L Barnhill; David E Elder; Michael W Piepkorn; Lisa M Reisch; Gaia Pocobelli; Patricia A Carney; Joann G Elmore
Journal:  J Am Acad Dermatol       Date:  2014-09-16       Impact factor: 11.527

Review 9.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

10.  Invasive size is an independent predictor of survival in pulmonary adenocarcinoma.

Authors:  Alain C Borczuk; Fang Qian; Angeliki Kazeros; Jennifer Eleazar; Adel Assaad; Joshua R Sonett; Mark Ginsburg; Lyall Gorenstein; Charles A Powell
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.